Privacy Policy
Signals Blog

Contributors

Categories

How CRISPR is democratizing genetic testing

Scientists have enlisted the gene editing tool CRISPR in a hunt for cancer causing mutations, releasing into the open valuable data that could help doctors better advise their patients. A new study lists almost 4,000 individual “misspellings,” or variants, in the...

Digital health: The new frontier of diagnosis?

Meredith O’Brien is the Communications Coordinator at CCRM. Meredith graduated with a Bachelor of Arts, Honours in Film and Media from Queen’s University. While writing her fourth-year thesis titled “iViral: The power of the individual in driving viral content,” she...

Update from the Clinic: November

Welcome to your Update from the Clinic for the month of November. There were a number of mid-stage clinical trials launched by cell-based immunotherapy companies this past month, furthering a robust global pipeline of CAR/TCR products. We also saw some efficacy data...

Right Turn: Cancer campaigns

To some people, November is now Movember. That is testament to how successful and pervasive this campaign for men’s health – especially prostate cancer – has become. (Blogger Sara Nolte has also chosen to write about prostate cancer during Movember.) Last month the...